About
Regenerative Medicine
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalSan Diego & Southern California
Team (8)
Brian Culley
Lineage Cell Therapeutics
team_member
Charlotte Hubbert, Ph.D.
Lineage Cell Therapeutics
team_member
Derek Kelaita
Lineage Cell Therapeutics
team_member
George A. Samuel III
Lineage Cell Therapeutics
team_member
Jennifer Bahr-Davidson, Ph.D.
Lineage Cell Therapeutics
team_member
Jill Howe
Lineage Cell Therapeutics
team_member
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
70
By Phase
PHASE1: 2PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
Hover over trial bars to see details
Recent Trials
NCT06841770Lead Sponsor
A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury
PHASE1Recruiting
10 participants
Started: Jun 30, 2025 · Completed: Jun 30, 2037
NCT05975424Lead Sponsor
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1
N/AActive, not recruiting
25 participants
Started: Jun 13, 2018 · Completed: Jan 14, 2033
NCT02302157Lead Sponsor
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
PHASE1/PHASE2Completed
25 participants
Started: Mar 31, 2015 · Completed: Dec 31, 2018
NCT05919563Lead Sponsor
LTFU Study of Subjects Who Received GRNOPC1
N/AActive, not recruiting
5 participants
Started: Oct 6, 2011 · Completed: Dec 12, 2026
NCT01217008Lead Sponsor
Safety Study of GRNOPC1 in Spinal Cord Injury
PHASE1Completed
5 participants
Started: Oct 31, 2010 · Completed: Jul 31, 2013
Locations (1)
Headquarters
Carlsbad, CA, United States
Map
Loading map...